Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testis cancer necessary?
D001761:Bleomycin / Q000627:therapeutic use; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D010984:Platinum / Q000627:therapeutic use; D011788:Quality of Life; D012187:Retroperitoneal Space; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000601:surgery; D014747:Vinblastine / Q000627:therapeutic use
D001761:Bleomycin; D003609:Dactinomycin; D010984:Platinum; D014747:Vinblastine